Johnson & Johnson vaccine less effective against Delta variant: study
July 21 2021, 08:00
A recent study from researchers at NYU’s Grossman School of Medicines found that the Johnson & Johnson vaccine may be less effective in battling COVID-19 variants than vaccines made by Pfizer-BioNTech or Moderna.
A recent study from researchers at NYU’s Grossman School of Medicines found that the Johnson & Johnson vaccine may be less effective in battling COVID-19 variants than vaccines made by Pfizer-BioNTech or Moderna.
Source:
FOX News